---

---

symbols : Nvs   

save search

---

Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published: 2024-02-09 (Crawled : 10:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K |

Health Technology

| -12.38% | O: -0.91% H: 3.88% C: 3.88%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 8.24% | O: -2.6% H: 2.26% C: 1.44%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -9.35% | O: -2.46% H: 0.0% C: 0.0%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -12.95% | O: 4.66% H: 0.0% C: -3.92%
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -7.8% | O: -0.04% H: 0.11% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -8.17% | O: -0.37% H: 0.21% C: 0.05%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -6.02% | O: 0.33% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| 0.04% | O: 1.11% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 7.47% | O: -1.28% H: 1.05% C: -0.72%
research global market

---

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K |

n/a

| 471.43% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -1.05% | O: -1.64% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -5.45% | O: -0.34% H: 0.0% C: -1.2%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.03% | O: -1.57% H: 0.26% C: -0.47%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -5.76% | O: -0.48% H: 0.16% C: 0.0%
BAX | $39.65 0.33% 0.0% 2.3M |

Health Technology

| 0.81% | O: -0.96% H: 5.91% C: 3.74%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -5.72% | O: -1.41% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -2.21% | O: -2.25% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -9.78% | O: 0.38% H: 0.34% C: -0.72%
america growth market

---

Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -5.15% | O: 0.43% H: 0.67% C: 0.21%
BAX | $39.65 0.33% 0.0% 2.3M |

Health Technology

| -0.03% | O: 0.21% H: 0.24% C: -1.04%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -4.15% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -0.9% | O: 1.33% H: 0.0% C: 0.0%
BMRN S | $90.08 -0.43% -0.43% 940K |

Health Technology

| 1.44% | O: -0.38% H: 1.79% C: 0.22%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -15.55% | O: -0.18% H: 0.0% C: -6.22%
america therapeutics growth market

---

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K |

Health Technology

| -13.72% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $64.07 -4.38% 72K |

Manufacturing

| 37.02% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -14.23% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -7.13% | O: 0.07% H: 0.42% C: 0.07%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -7.04% | O: 1.47% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -2.03% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -4.15% | O: 1.48% H: 0.0% C: 0.0%
VRTX | News | $393.51 0.1% 0.1% 950K |

Health Technology

| -5.53% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -0.9% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $109.3 2.05% 2.01% 560K |

Health Technology

| -14.12% | O: -0.02% H: 0.0% C: -1.4%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -15.55% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

---

The Radiopharmaceuticals Market to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 42% to the growth - Technavio
Published: 2024-02-06 (Crawled : 09:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -9.75% | O: 0.72% H: 0.0% C: -1.56%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.04% | O: -0.15% H: 0.6% C: 0.42%
america growth market

---

Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash
Published: 2024-02-05 (Crawled : 22:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -9.75% | O: 0.72% H: 0.0% C: -1.56%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.04% | O: -0.15% H: 0.6% C: 0.42%
MOR | $18.02 -0.11% -0.11% 590K |

Health Technology

| 4.46% | O: 1.39% H: 0.34% C: -7.08%
pipeline acquire novartis agreement

---

Mondelēz International Appoints Brian McNamara to Board of Directors
Published: 2024-02-02 (Crawled : 14:00) - globenewswire.com
HLNCF | $3.94 -1.48% 1 |

n/a

| -5.29% | O: -2.64% H: 1.6% C: 1.48%
HLN | $8.13 0.25% -0.98% 4.8M |

n/a

| -3.45% | O: -0.48% H: 0.0% C: -0.6%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -11.63% | O: -0.5% H: 0.26% C: -1.03%
MDLZ | $67.18 1.01% 1.0% 8.7M |

Consumer Non-Durables

| -13.1% | O: 0.47% H: 0.38% C: -0.04%
international

---

United States Endometrial Cancer Research Report 2023
Published: 2024-02-02 (Crawled : 10:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -8.55% | O: 0.21% H: 0.49% C: -0.9%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -11.63% | O: -0.5% H: 0.26% C: -1.03%
report cancer research

---

Global Hairy Cell Leukemia Market Analysis & Forecast 2024-2034
Published: 2024-02-02 (Crawled : 03:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -11.63% | O: -0.5% H: 0.26% C: -1.03%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -8.41% | O: -0.15% H: 0.0% C: 0.0%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -0.84% | O: 1.23% H: 1.5% C: -1.14%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 0.19% | O: 3.59% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -17.75% | O: -0.28% H: 0.66% C: -0.14%
cell global leukemia market

---

Vertigo Drugs Market Research Report 2023 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2028F
Published: 2024-02-01 (Crawled : 18:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K |

n/a

| 566.67% | O: -83.33% H: 500.0% C: 500.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 1.0% | O: -0.7% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -11.63% | O: -0.5% H: 0.26% C: -1.03%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -2.54% | O: -0.05% H: 0.59% C: 0.27%
report research global market

---

Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published: 2024-02-01 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -1.68% | O: -1.29% H: 0.0% C: -1.38%
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -6.13% | O: 0.07% H: 0.83% C: 0.7%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.04% | O: 1.55% H: 0.79% C: 0.25%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 0.41% | O: 1.27% H: 1.87% C: 1.73%
EMN | $96.02 0.05% 0.0% 680K |

Process Industries

| 15.38% | O: 0.79% H: 0.8% C: 0.77%
drug expansion global growing

---

Opthea Strengthens Team with Key Clinical and Regulatory Hires
Published: 2024-02-01 (Crawled : 11:00) - globenewswire.com
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -10.04% | O: 1.55% H: 0.79% C: 0.25%
ALC | $78.47 -0.67% -0.01% 760K |

Health Technology

| 5.99% | O: 0.24% H: 1.54% C: 1.46%
OPT | $3.41 0.29% 0.29% 2.7K |

Health Technology

| 25.46% | O: -0.74% H: 6.84% C: 2.6%
key

---

Global Respiratory Drug Delivery Market Report 2024 - A US$67 Billion Market - Trends in Metered Dose Inhaler (MDI) Technology to Propel the Market
Published: 2024-01-31 (Crawled : 17:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
PHG | $19.98 -0.84% 0.0% 500K |

Health Technology

| -5.97% | O: -0.09% H: 0.93% C: -1.31%
drug propel report respiratory global trends technology market

---

Novartis delivers strong full year performance, 10% net sales and 18% core operating income growth (cc¹), with margin expansion. Continuing innovation momentum with multiple positive Ph3 readouts
Published: 2024-01-31 (Crawled : 06:00) - globenewswire.com
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
sales year momentum positive innovation novartis growth

---

Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-01-30 (Crawled : 23:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K |

Health Technology

| -16.94% | O: 4.34% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 3.09% | O: 3.41% H: 0.0% C: -2.45%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -19.27% | O: 0.0% H: 1.38% C: 0.26%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -6.01% | O: -0.08% H: 3.47% C: -0.25%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 1.3% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -0.6% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.28% | O: 1.75% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 1.58% | O: 0.82% H: 0.12% C: -1.64%
market

---

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 3.09% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.11 0.09% 0.09% 3.5M |

Health Technology

| -6.01% | O: -0.08% H: 3.47% C: -0.25%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 1.3% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -0.6% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.28% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.98 -3.68% -3.82% 290K |

Health Technology

| 8.5% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 1.58% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -15.16% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

---

Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K |

Health Technology

| -15.47% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
ALPMY | $9.46 -1.11% 500K |

Manufacturing

| -19.48% | O: -3.53% H: 3.49% C: 3.4%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -13.77% | O: -0.59% H: 0.49% C: 0.41%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 1.38% | O: 0.26% H: 0.13% C: -0.18%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 0.01% | O: 0.19% H: 0.46% C: 0.43%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -8.17% | O: 0.12% H: 0.0% C: 0.0%
kidney renal expected million therapeutics growth market

---

Antibacterial Drugs Market Report 2024-2034, Featuring Profiles of AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer & Sanofi
Published: 2024-01-26 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 2.46% | O: -1.67% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -6.6% | O: 1.8% H: 0.0% C: -1.82%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -13.0% | O: 0.29% H: 0.15% C: -0.13%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -9.0% | O: 0.8% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| 1.96% | O: 1.36% H: 0.23% C: -0.76%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -2.72% | O: 0.71% H: 0.48% C: -0.52%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| 0.01% | O: 0.85% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -7.6% | O: 0.5% H: 0.0% C: 0.0%
report antibacterial sanofi market

---

Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published: 2024-01-26 (Crawled : 15:30) - prnewswire.com
TAK | News | $13.16 0.08% 0.0% 1.3M |

Health Technology

| -10.12% | O: -0.27% H: 0.38% C: 0.07%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -13.0% | O: 0.29% H: 0.15% C: -0.13%
SRPT | $116.59 -1.1% -1.12% 500K |

Health Technology

| -1.77% | O: 0.69% H: 0.12% C: -1.75%
GILD | News | $66.16 -1.15% -1.16% 6.4M |

Health Technology

| -16.58% | O: 0.0% H: 0.35% C: -0.88%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -13.96% | O: 0.1% H: 0.47% C: 0.39%
market

---

Human Insulin Drugs Market In Brazil 2023-2028: Market Analysis, Drivers, Restraints, Opportunities, and Threats - 17000 + Technavio Reports
Published: 2024-01-26 (Crawled : 03:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -6.6% | O: 1.8% H: 0.0% C: -1.82%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -13.0% | O: 0.29% H: 0.15% C: -0.13%
MDT | $79.19 0.14% 0.0% 6.1M |

Health Technology

| -7.82% | O: 0.47% H: 0.48% C: 0.41%
ACN | $316.0 0.46% 0.0% 3M |

Technology Services

| -15.43% | O: -0.01% H: 0.6% C: -0.23%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -7.6% | O: 0.5% H: 0.0% C: 0.0%
brazil insulin market

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---